APA (7th ed.) Citation

Lessiak, U., Brandstoetter, T., Nell, B., Klein, K., Mlynek, G., Wimmer, L., . . . Hoelbl-Kovacic, A. (2025). Preserved bevacizumab (Avastin®) eye drops for application in multidose containers – an in-vitro characterisation. BMC Veterinary Research, 21(1), 1. https://doi.org/10.1186/s12917-025-04592-4

Chicago Style (17th ed.) Citation

Lessiak, Ulrike, Tania Brandstoetter, Barbara Nell, Klara Klein, Georg Mlynek, Lukas Wimmer, Lisa Scheiblecker, Alexander Tichy, and Andrea Hoelbl-Kovacic. "Preserved Bevacizumab (Avastin®) Eye Drops for Application in Multidose Containers – an In-vitro Characterisation." BMC Veterinary Research 21, no. 1 (2025): 1. https://doi.org/10.1186/s12917-025-04592-4.

MLA (9th ed.) Citation

Lessiak, Ulrike, et al. "Preserved Bevacizumab (Avastin®) Eye Drops for Application in Multidose Containers – an In-vitro Characterisation." BMC Veterinary Research, vol. 21, no. 1, 2025, p. 1, https://doi.org/10.1186/s12917-025-04592-4.